Rachael Lester - 20 Oct 2025 Form 3 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Signature
/s/ Christopher Ogden, as Attorney-in-Fact for Rachael Lester
Issuer symbol
CTMX
Transactions as of
20 Oct 2025
Net transactions value
$0
Form type
3
Filing time
29 Oct 2025, 16:49:49 UTC
Next filing
04 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lester Rachael Chief Business Officer C/O CYTOMX THERAPEUTICS, INC., 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO /s/ Christopher Ogden, as Attorney-in-Fact for Rachael Lester 29 Oct 2025 0002094324

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney